wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36076453-F63E0D7F-20D5-4412-92AF-2A7FD7C3C94C
Q36076453-F63E0D7F-20D5-4412-92AF-2A7FD7C3C94C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36076453-F63E0D7F-20D5-4412-92AF-2A7FD7C3C94C
Future perspectives of prostate cancer therapy.
P2860
Q36076453-F63E0D7F-20D5-4412-92AF-2A7FD7C3C94C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36076453-F63E0D7F-20D5-4412-92AF-2A7FD7C3C94C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6db0e735b109e355471273daacd4388763facc42
P2860
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study.